Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages

Human Gene Therapy

Volumn 10, Issue 8, 1999, Pages 1389-1399

  Auten, Jennifer ^a   Agarwal, Manju ^a   Chen, Jingyi ^a   Sutton, Richard ^b   Plavec, Ivan ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD14 ANTIGEN; CD33 ANTIGEN; CD4 ANTIGEN; REV PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MOLONEY LEUKEMIA ONCOVIRUS; MONOCYTE; RETROVIRUS; T LYMPHOCYTE; TRANSGENE; VIRUS GENE;

ANIMALS; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION; GENE PRODUCTS, REV; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIV-1; HUMANS; INTERFERON-BETA; KINETICS; MACROPHAGES; MICE; MOLONEY MURINE LEUKEMIA VIRUS; MONOCYTES; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSFECTION; TRANSGENES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; UNIDENTIFIED RETROVIRUS;

EID: 0033587191     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018058     Document Type: Article

References (53)

1. AGARWAL, M., AUSTIN, T.W., MOREL, F., CHEN, J., BÖHNLEIN, E., and PLAVEC, I. (1998). Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J. Virol. 72, 3720-3728.
2. ANDERSON, F. (1998). Human gene therapy. Nature (London) 392(Suppl.), 25-30.
3. BAUM, C.M., WEISSMAN, I.L., TSUKAMOTO, A.S., BUCKLE, A.M., and PEAULT, B. (1992). Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. U.S.A. 89, 2804-2808.
4. BAUM, C., HEGEWISCH-BECKER, S., ECKERT, H.G., STOCKING, C., and OSTERTAG, W. (1995). Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J. Virol. 69, 7541-7547.
5. BERWIN, B., and BARKLIS, E. (1993). Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations. Nucleic Acids Res. 21, 2399-2407.
6. BODE, J., KOHWI, Y., DICKINSON, L., JOH, T., KLEHR, D., MIELKE, C., and KOHWI-SHIGEMATSU, T. (1992). Biological significance of unwinding capability of nuclear matrix-associated DNAs. Science 255, 195-197.
7. BODE, J., SCHLAKE, T., RÍOS-RAMÍREZ, M., MIELKE, C., STENGERT, M., KAY, V., and KLEHR, W.D. (1995). Scaffold/Matrix-Attachment Regions (S/MAR): Structural Properties Creating Transcriptionally Active loci. K.W. Jeon and R. Berezney, eds. (Academic Press, Orlando, FL).
8. BONYHADI, M., MOSS, K., VOYTOVITCH, A., AUTEN, J., KALFOGLOU, C., PLAVEC, I., FORESTELL, S., SU, L., BÖHNLEIN, E., and KANESHIMA, H. (1997). RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J. Virol. 71, 4707-4716.
9. BOULIKAS, T. (1993). Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J. Cell. Biochem. 52, 14-22.
10. BRENNER, M.K. (1995). Human somatic gene therapy: Progress and problems. J. Intern. Med. 237, 229-239.
11. BUNNELL, B.A., METZGER, M., BYRNE, E., MORGAN, R.A., and DONAHUE, R.E. (1997). Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 89, 1987-1995.
12. BURNS, J.C., FRIEDMANN, T., DRIEVER, W., BURRASCANO, M., and YEE, J.K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90, 8033-8037.
13. CHALLITA, P.M., and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 2567-2571.
14. ESCAICH, S., KALFOGLOU, C., PLAVEC, I., KAUSHAL, S., MOSCA, J.D., and BÖHNLEIN, E. (1995). RevM10-mediated inhibition of HIV-1 replication in chronically infected T cells. Hum. Gene Ther. 6, 625-634.
15. FLANAGAN, J.R., KRIEG, A.M., MAX, E.E., and KHAN, A.S. (1989). Negative control region at the 5′ end of murine leukemia virus long terminal repeats. Mol. Cell. Biol. 9, 739-746.
16. FORESTELL, S.P., BÖHNLEIN, E., and RIGG, R.J. (1995). Retroviral end-point titer is not predictive of gene transfer efficiency: Implications for vector production. Gene Ther. 2, 723-730.
17. GERASIMOVA, T.I., and GORGES, V.G. (1996). Boundary and insulator elements in chromosomes. Curr. Opin. Genet. Dev. 6, 185-192.
18. HAWLEY, R.G., LIEU, F.H.L., FONG, A.Z.C., and HAWLEY, T.S. (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1, 136-138.
19. HERRMANN, C.H., CARROLL, R.G., WEI, P., JONES, K.A., and RICE, A.W. (1998). Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J. Virol. 72, 9881-9888.
20. JANG, S.K., DAVIES, M.V., KAUFMAN, R.J., and WIMMER, E. (1989). Initiation of protein synthesis by internal entry of ribosomes into 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J. Virol. 63, 1651-1660.
21. JENUWEIN, T., FORRESTER, W.C., FERNÁNDEZ-HERRERO, L.A., LAIBE, G., DULL, M., and GROSSCHEDL, R. (1997). Extension of chromatin accessibility by nuclear matrix attachment regions. Nature (London) 385, 269-272.
22. JOHNSON, D., LANAHAN, A., BUCK, C.R., SEHGAL, A., MORGAN, C., MERCER, E., BOTHWELL, M., and CHAO, M. (1986). Expression and structure of the human NGF receptor. Cell 47, 545-554.
23. JUNKER, U., MOON, J.J., KALFOGLOU, C.S., SNIECINSKI, I., FORMAN, S.J., ZAIA, J.A., KANESHIMA, H., and BÖHNLEIN, E. (1997). Hematopoietic potential and retroviral transduction of CD34+Thy-1+peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony-stimulating factor. Blood 89, 4299-4306.
24. JUNKER, U., KALFOGLOU, C.S., MOON, J.J., BECK, M.K., KANESHIMA, E., and BÖHNLEIN, E. (1998). Inhibition of human immunodeficiency virus type 1 replication in myelomonocytic cells derived from retroviral vector-transduced peripheral blood progenitor cells. Hum. Gene Ther. 9, 333-340.
25. KALOS, M., and FOURNIER, R.E.K. (1995). Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain. Mol. Cell. Biol. 15, 198-207.
26. KIOUSSIS, D., and FESTENSTEIN, R. (1997). Locus control regions: Overcoming heterochromatin-induced gene inactivation in mammals. Curr. Opin. Genet. Dev. 7, 614-619.
27. KLEHR, D., MAASS, K., and BODE, J. (1991). Scaffold-attached regions from the human interferon β domain can be used to enhance stable expression of genes under the control of various promoters. Biochemistry 30, 1264-1270.
28. LEWIS, W.S., CODY, V., GALITSKY, N., LUFT, J.R., PANGBORN, W., CHUNDURU, S.K., SPENCER, H.T., APPLEMAN, J.R., and BLAKLEY, R.L. (1995). Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22. J. Biol. Chem. 270, 5057-5064.
29. LU, M., ZHANG, N., MARUYAMA, M., HAWLEY, R.G., and HO, A.D. (1996). Retrovirus-mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation. Hum. Gene Ther. 7, 2263.
30. MALIM, M.H., BÖHNLEIN, S., HAUBER, J., and CULLEN, B.R. (1989). Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 58, 205-214.
31. MAVILIO, F., FERRARI, G., ROSSINI, S., NOBILI, N., BONINI, C., CASORATI, G., TRAVERSARI, C., and BORDIGNON, C. (1994). Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83, 1988-1997.
32. MCKNIGHT, R.A., SHAMAY, A., SANKARAN, L., WALL, R.J., and HENNIGHAUSEN, L. (1992). Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 89, 6943-6947.
33. MIELKE, C., KOHWI, Y., KOHWI-SHIGEMATSU, T., and BODE, J. (1990). Hierarchical binding of DNA fragments derived from scaffold-attached regions: Correlation of properties in vitro and function in vivo. Biochemistry 29, 7475-7485.
34. MILLER, A.D. (1992). Human gene therapy comes of age. Nature (London) 357, 455-460.
35. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
36. NOVAK, U., HARRIS, E.A.S., FORRESTER, W., GROUDINE, M., and GELINAS, R. (1990). High-level β-globin expression after retroviral transfer of locus activation region-containing human β-globin gene derivatives into murine erythroleukemia cells. Proc. Natl. Acad. Sci. U.S.A. 87, 3386-3390.
37. PAWLIUK, R., EAVES, C.J., and HUMPHRIES, R.K. (1997). Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. Hum. Gene Ther. 8, 1595-1604.
38. PEAR, W.S., NOLAN, G.P., SCOTT, M.L., and BALTIMORE, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396.
39. PETERSEN, R., KEMPLER, G., and BARKLIS, E. (1991). A stem cell-specific silencer in the primer-binding site of retrovirus. Mol. Cell. Biol. 11, 1214-1227.
40. PLAVEC, L. PAPAYANNOPOULOU, T., MAURY, C., and MEYER, F. (1993). A human β-globin gene fused to the human β-globin locus control region is expressed at high levels in erythroid cells of mice engrafted with retrovirus-transduced hematopoietic stem cells. Blood 81, 1384-1392.
41. PLAVEC, I., AGARWAL, M., HO, K.E., PINEDA, M., AUTEN, J., BAKER, J., MATSUZAKI, H., ESCAICH, S., BONYHADI, M., and BÖHNLEIN, E. (1997). High trans-dominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: Implication for gene therapy of AIDS. Gene Ther. 7, 128-139.
42. POLJAK, L., SEUM, C., MATTIONI, T., and LAEMMLI, U.K. (1994). SARs stimulate but do not confer position independent gene expression. Nucleic Acids Res. 22, 4386-4394.
43. RIGG, J.R., CHEN, J., DANDO, J.S., FORESTELL, S.P., PLAVEC, I., and BÖHNLEIN, E. (1996). A novel human amphotropic packaging cell line: High titer, complement resistance, and improved safety. Virology 218, 290-295.
44. RIGG, R.J., DANDO, J.S., ESCAICH, S., PLAVEC, I., and BÖHNLEIN, E. (1995). Detection of intracellular HIV-1 Rev protein by flow cytometry. J. Immunol. Methods 188, 187-195.
45. RIVIÈRE, I., BROSE, K., and MULLIGAN, R.C. (1995). Effect of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. U.S.A. 92, 6733-6737.
46. ROBBINS, P.B., SKELTON, D.C., YU, X.J., HALENE, S., LEONARD, E.H., and KOHN, D.B. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 95, 10182-10187.
47. SIMONSEN, C.C., and LEVINSON, A.D. (1983). Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc. Natl. Acad. Sci. U.S.A. 80, 2495-2499.
48. SPENCER, H.T., SLEEP, S.E.H., REHG, J.E., BLAKLEY, R.L., and SORRENTINO, B.P. (1996). A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87, 2579-2587.
49. SUTTON, R.E., WU, H.T.M., RIGG, R., BÖHNLEIN, E., and BROWN, P.O. (1998). Human immunodeficiency virus type I vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72, 5781-5788.
50. TAGAWA, M., NAKAUCHI, L., HERZENBERG, L.A., and NOLAN, G.P. (1986). Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation. Proc. Natl. Acad. Sci. U.S.A. 83, 3422-3426.
51. THOMPSON, E.M., CHRISTIANS, E., STINNAKRE, M.-G., and RENARD, J.-P. (1994). Scaffold attachment region stimulate HSP70.1 expression in mouse preimplantation embryos but not in differentiated tissues. Mol. Cell. Biol. 14, 4694-4703.
52. TUMAS, D.B., SPANGRUDE, G.J., BROOKS, D.M., WILLIAMS, C.D., and CHESEBRO, B. (1996). High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector. Blood 87, 509-517.
53. VANDENDRIESCHE, T., CHUAH, M.K.L., CHIANG, L., CHANG, H.K., ENSOLI, B., and MORGAN, R.A. (1995). Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes. J. Virol. 69, 4045-4052.